Daxor Corp
NASDAQ:DXR
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
US |
Daxor Corp
NASDAQ:DXR
|
46.5m USD | -73.1 | ||
US |
Abbott Laboratories
NYSE:ABT
|
182.1B USD | 8.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.7B USD | 27.1 | ||
US |
Stryker Corp
NYSE:SYK
|
126B USD | 10 | ||
IE |
Medtronic PLC
NYSE:MDT
|
110B USD | 6 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
108.9B USD | 11.3 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 10 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58.6B EUR | 8.8 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
52.6B USD | 11 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 20.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
366.7B CNY | 15.7 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.